To understand Key Opinion Leaders perspectives around the accessibility and acceptability of emerging treatment options along with GLP-1 agonists unmet need of current therapies Details on report methodology, top indications covered, market assumptions, patient journey and KOLs to strengthen the pharmaceutical companies development and launch strategy.
What to do: If you notice any of these symptoms, consult your healthcare provider immediately
Protocol 3: metabolic health optimization Goal: Reduce liver fat, improve insulin sensitivity, address metabolic syndrome Tirzepatide approach: Standard escalation to 10 mg Produces moderate liver fat reduction Significant HbA1c improvements (if diabetic) Meaningful but not maximal metabolic improvements Retatrutide approach: Escalation to 8-12 mg 86% of patients achieved normal liver fat at 12 mg Superior metabolic marker improvements across all measures Glucagon component directly targets hepatic lipid metabolism If metabolic health is your primary goal rather than the number on the scale, the retatrutide dosage chart offers something tirzepatide fundamentally cannot: direct glucagon-mediated liver fat reduction
10.1038/s41467-024-48616-3 162 ZhangH.YangJ.SunR.HanS.YangZ.TengL
Tell your health care professional if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath
